Skip to main content
. 2016 Dec 29;107(12):1843–1850. doi: 10.1111/cas.13098

Figure 1.

Figure 1

Kaplan–Meier plots of (a) overall survival and (b) progression‐free survival in the full analysis set cohort. Bmab, bevacizumab; CI, confidence interval; HR, hazard ratio; Pmab, panitumumab.